| Case No. |
Sex/ Age |
Site |
Size (cm) |
Cell type |
Metastasis |
Mitosis /50HPF |
Stage TNM |
Treatment |
Prognosis |
Months of follow-up |
| Retrospective study |
| 1 |
F/62 |
rectum |
7 |
M |
None |
3 |
II |
surgery |
ANED |
14 |
| 2 |
F/83 |
stomach |
6 |
S |
None |
1 |
I B |
surgery |
ANED |
50 |
| 3 |
M/79 |
rectum |
5 |
S |
None |
20 |
III B |
surgery, imatinib |
ANED |
43 |
| 4 |
F/62 |
stomach |
4.5 |
S |
None |
4 |
I A |
surgery |
NA |
- |
| 5 |
M/68 |
stomach |
8 |
M |
None |
2 |
I B |
surgery |
ANED |
43 |
| 6 |
M/55 |
jejunum |
3 |
S |
PD |
8 |
IV |
surgery, imatinib |
REC |
40 |
| 7 |
M/53 |
ileum |
1.5 |
S |
None |
4 |
I |
surgery |
NA |
- |
| 8 |
F/81 |
stomach |
7 |
M |
None |
1 |
I B |
surgery |
MOM |
9 |
| 9 |
F/54 |
stomach |
3.6 |
S |
None |
2 |
I A |
surgery |
NA |
- |
| 10 |
M/66 |
stomach |
1 |
S |
None |
2 |
I A |
surgery |
ANED |
52 |
| 11 |
M/67 |
stomach |
12 |
S |
None |
143 |
III B |
surgery |
NA |
- |
| 12 |
M/45 |
stomach |
2 |
S |
None |
2 |
I A |
surgery |
ANED |
51 |
| 13 |
F/70 |
rectum |
2.5 |
S |
None |
3 |
I |
surgery |
NA |
- |
| 14 |
F/68 |
stomach |
4.6 |
S |
None |
3 |
I A |
surgery |
ANED |
47 |
| 15 |
M/71 |
stomach |
4.4 |
S |
None |
2 |
I A |
surgery |
ANED |
42 |
| 16 |
F/64 |
jejunum |
2 |
M |
None |
0 |
I |
surgery |
NA |
- |
| 17 |
F/53 |
stomach |
3.2 |
S |
None |
8 |
II |
surgery |
ANED |
54 |
| 18 |
M/52 |
jejunum |
9.5 |
S |
None |
41 |
IIIB |
surgery, imatinib |
MET |
29 |
| 19 |
F/53 |
ileum |
6.5 |
M |
None |
1 |
II |
surgery |
NA |
- |
| 20 |
M/62 |
stomach |
57 |
M |
None |
43 |
III B |
surgery |
ANED |
62 |
| 21 |
F/74 |
stomach |
7.5 |
E |
None |
4 |
I B |
surgery, imatinib |
AWD |
60 |
| 22 |
F/65 |
stomach |
3 |
S |
None |
14 |
II |
surgery |
ANED |
63 |
| 23 |
M/48 |
stomach |
2 |
S |
None |
1 |
I A |
surgery |
ANED |
61 |
| 24 |
M/73 |
stomach |
4 |
M |
None |
0 |
I A |
surgery |
ANED |
52 |
| 25 |
M/74 |
stomach |
16 |
S |
PD |
21 |
IV |
surgery, imatinib |
DOD |
27 |
| 26 |
M/66 |
stomach |
4.7 |
S |
None |
9 |
III B |
surgery, imatinib |
ANED |
24 |
| Prospective study |
| 27 |
M/59 |
stomach |
9 |
S |
LN |
3 |
IV |
surgery, imatinib |
MOM |
6 |
| 28* |
M/56 |
duodenum |
NB |
S |
Liver |
0 |
- |
imatinib |
|
|
| |
|
|
16 |
M |
Liver |
18 |
IV |
surgery, sunitinib |
DOD |
51 |
| 29 |
M/62 |
stomach |
3.5 |
S |
None |
8 |
II |
surgery |
ANED |
12 |
| 30 |
M/70 |
stomach |
0.6 |
S |
None |
0 |
I A |
surgery |
ANED |
14 |
| 31 |
F/57 |
stomach |
1 |
M |
None |
1 |
I A |
surgery |
ANED |
14 |
| 32 |
M/54 |
stomach |
3.5 |
S |
None |
5 |
I A |
surgery |
ANED |
10 |
| 33 |
F/59 |
stomach |
7 |
M |
None |
7 |
III A |
surgery |
NA |
- |
| 34 |
M/74 |
stomach |
1.8 |
M |
None |
0 |
I A |
surgery |
NA |
- |
| 35 |
F/65 |
colon |
6 |
M |
None |
6 |
III B |
surgery |
NA |
- |
| 36 |
F/75 |
jejunum |
10 |
M |
None |
6 |
III B |
surgery |
ANED |
12 |
| 37 |
F/67 |
stomach |
11 |
M |
None |
5 |
II |
surgery |
ANED |
10 |
| 38 |
M/69 |
stomach |
4 |
M |
None |
2 |
I A |
surgery |
ANED |
6 |
| 39 |
M/83 |
stomach |
5.5 |
E |
None |
3 |
I B |
surgery |
NA |
- |
| 40 |
M/23 |
duodenum |
3 |
S |
None |
6 |
II |
surgery |
ANED |
4 |
| 41 |
F/66 |
stomach |
3.5 |
S |
None |
1 |
I A |
surgery |
ANED |
6 |
| 42 |
M/69 |
stomach |
3.5 |
M |
None |
24 |
II |
surgery |
ANED |
3 |
ANED: Alive No Evidence Of Disease; AWD: Alive With Disease; DOD: Died Of Disease; E: Epithelioid; LN: Lymph Node; M: Mix; MET: Metastasis; MOM: Multiple
Organ Metastasis; NA: Not Available; NB: Needle Biopsy; PD: Peritoneum Dissemination; REC: Recurrence; S: Spindle; TNM: Tumor, Lymph Node and Metastasis.
Case Nos.1-26 included in the retrospective study, 27-42 included in the prospective study. *Case 28 had two samples that were obtained before and after imatinib
therapy. |
